BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30635211)

  • 21. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis.
    Cho YK; Kim JK; Kim WT; Chung JW
    Hepatology; 2010 Apr; 51(4):1284-90. PubMed ID: 20099299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma.
    Wang X; Wang Z; Wu L
    BMC Surg; 2016 Apr; 16():22. PubMed ID: 27094483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].
    Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Hwang YJ; Kim YI
    Korean J Hepatol; 2005 Mar; 11(1):59-71. PubMed ID: 15788886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Radiofrequency Ablation and Hepatic Resection for the Treatment of Hepatocellular Carcinoma 2 cm or Less.
    Huang Y; Shen Q; Bai HX; Wu J; Ma C; Shang Q; Hunt SJ; Karakousis G; Zhang PJ; Zhang Z
    J Vasc Interv Radiol; 2018 Sep; 29(9):1218-1225.e2. PubMed ID: 30075975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-world role of performance status in surgical resection for hepatocellular carcinoma: A multicenter study.
    Wu H; Xing H; Liang L; Huang B; Li C; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zhang YM; Zeng YY; Pawlik TM; Wang MD; Wu MC; Shen F; Yang T
    Eur J Surg Oncol; 2019 Dec; 45(12):2360-2368. PubMed ID: 31543386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma.
    Ng KKC; Chok KSH; Chan ACY; Cheung TT; Wong TCL; Fung JYY; Yuen J; Poon RTP; Fan ST; Lo CM
    Br J Surg; 2017 Dec; 104(13):1775-1784. PubMed ID: 29091283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases.
    Di Sandro S; Centonze L; Pinotti E; Lauterio A; De Carlis R; Romano F; Gianotti L; De Carlis L;
    Updates Surg; 2019 Jun; 71(2):285-293. PubMed ID: 30941704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
    Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
    Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplant offers a survival benefit over margin negative resection in patients with small unifocal hepatocellular carcinoma and preserved liver function.
    Benjamin AJ; Baker TB; Talamonti MS; Bodzin AS; Schneider AB; Winschester DJ; Roggin KK; Bentrem DJ; Suss NR; Baker MS
    Surgery; 2018 Mar; 163(3):582-586. PubMed ID: 29370929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparities in care for patients with curable hepatocellular carcinoma.
    Hoehn RS; Hanseman DJ; Jernigan PL; Wima K; Ertel AE; Abbott DE; Shah SA;
    HPB (Oxford); 2015 Sep; 17(9):747-52. PubMed ID: 26278321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Outcomes of Hepatic Resection and Radiofrequency Ablation for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the Barcelona-Clinic Liver Cancer Stage A Classification.
    Jiang L; Yan L; Wen T; Li B; Zeng Y; Yang J; Wang W; Xu M; Wu H
    J Am Coll Surg; 2015 Nov; 221(5):951-61. PubMed ID: 26362135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or =4 cm.
    Wakai T; Shirai Y; Suda T; Yokoyama N; Sakata J; Cruz PV; Kawai H; Matsuda Y; Watanabe M; Aoyagi Y; Hatakeyama K
    World J Gastroenterol; 2006 Jan; 12(4):546-52. PubMed ID: 16489666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nationwide propensity score analysis comparing ablation and resection for hepatocellular carcinoma.
    Rasic G; de Geus SWL; Beaulieu-Jones B; Kasumova GG; Kent TS; Ng SC; McAneny D; Tseng JF; Sachs TE
    J Surg Oncol; 2023 Jun; 127(7):1125-1134. PubMed ID: 36905338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic resection combined with radiofrequency ablation versus hepatic resection alone for multifocal hepatocellular carcinomas: A meta-analysis.
    Xu LL; Zhang M; Yi PS; Zheng XB; Feng L; Lan C; Tang JW; Ren SS; Xu MQ
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):974-980. PubMed ID: 29270762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting.
    Takayasu K; Arii S; Sakamoto M; Matsuyama Y; Kudo M; Kaneko S; Nakashima O; Kadoya M; Izumi N; Takayama T; Ku Y; Kumada T; Kubo S; Kokudo T; Hagiwara Y; Kokudo N;
    Liver Int; 2018 Mar; 38(3):484-493. PubMed ID: 29266722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: A propensity score matching study.
    Qiu J; Zheng Y; Shen J; Zeng QA; Zou R; Liao Y; He W; Li Q; Chen G; Li B; Yuan Y
    Surgery; 2015 Nov; 158(5):1235-43. PubMed ID: 25958066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiofrequency ablation versus open hepatic resection for elderly patients (> 65 years) with very early or early hepatocellular carcinoma.
    Peng ZW; Liu FR; Ye S; Xu L; Zhang YJ; Liang HH; Lin XJ; Lau WY; Chen MS
    Cancer; 2013 Nov; 119(21):3812-20. PubMed ID: 23922119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical resection of early stage hepatocellular carcinoma improves patient survival at safety net hospitals.
    Vitiello GA; Wang A; Lee RM; Russell MC; Yopp A; Ryon EL; Goel N; Luu S; Hsu C; Silberfein E; Correa-Gallego C; Berman RS; Lee AY
    J Surg Oncol; 2021 Mar; 123(4):963-969. PubMed ID: 33497478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.